3,489 Followers on Owler

23andMe

is an online healthcare platform that provides DNA genetic testing for individuals and uses that information for health research... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

23andMe

is an online healthcare platform that provides DNA genetic testing for individuals and uses that information for health research... Read more
23andMe Interim-CEO: Joe Selsavage

Interim-CEO

Joe Selsavage

CEO Approval Rating

77/100

2006

PublicAcquisition Pending from The TTAM Research InstituteNASDAQME

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$174.9M
Employees
770
Funding
$1.5B
Acquisitions
2

News

Leadership Change
Dec 09, 2025
Benzinga
John McLeod joined 23andMe as General Counsel and Chief Risk Officer
Acquisition
May 19, 2025
Citybizlist
23andMe Was acquired by Regeneron Pharmaceuticals, Inc. for $256M

23andMe Competitors

1MyHeritage
2Ancestry
3Dante Labs
4tellmeGen
5Ambry
6ORIG3N
Unlock 3 + competitors

Trending Companies